Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRavi, S-
dc.contributor.authorIndira, S-
dc.contributor.authorNatchimuthu, V-
dc.contributor.authorSengottaiyan, C-
dc.identifier.issn0975-1041 (Online); 0019-5596 (Print)-
dc.description.abstractThe experimental ultrasonic velocity has been measured for anticonvulsants such as Carbamazepine(CBZ), Oxycarbazepine(OXYCBZ) and Clobazam. The drugs are some of the most preferred for almost any kind of seizure. The highly non-soluble nature of such drugs in water might have not encouraged people to estimate the speed of sound through these drugs. In the present paper, based on the solubility of these drugs in DMSO (dimethylsulphoxide), water is gradually added to obtain different concentrations. The sound velocity is measured using 1 and 3 MHz interferometer specifically at room temperature. The sound velocity data is used to estimate the structural parameter which in turn exposes the similarity in behaviour of all the three drugs.en_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJPAP Vol.51(04) [April 2013]en_US
dc.subjectUltrasonic velocityen_US
dc.subjectStructure factoren_US
dc.titleUltrasonic study of 5H-dibenz[B,F]azepine-5-carboxamide and 7-chloro-1,5-dihydro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4(3H)-dioneen_US
Appears in Collections:IJPAP Vol.51(04) [April 2013]

Files in This Item:
File Description SizeFormat 
IJPAP 51(4) 241-244.pdf144.57 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.